Scared, you would think that Griffin knows that an institutional investment manager isn't going to touch a company like CDEx. It makes me wonder why he was pushing in that direction. It seemed as if he was trying to sell the BOD bios as much as the tech IMO.
I don't know if the lawyers would have appreciated him talking about the lawsuit.
I think he should have explained why CDEx has a better mousetrap than other companies in the spectroscopy business. Everyone keeps talking about how our tech is so much better than anything out there, but no one can explain why? How silly is that?
Capnmike can't. Ontheedge can't. Raiderman can't. And some of these guys claim to be in such close communication with WP that I would think the only thing they'd have to do is give him a call for a good explanation. That would go a long, long way in my book.
Griffin should have explained in laymen's terms why CDEx UFV tech is superior to others. What can it do that others can't? Is it faster? Is it more accurate? Repeatable? Higher sensitivity? Greater stand-off distance? Instead, he said it was better than a refractometer and better than sending it out to a lab. Very disappointing. You're not going to get big money investing in a penny stock bases on BOD bios IMO.
When developing a sales script, if you don't have a convincing and impressive answer don't ask the question.
